secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2023-02-13T23:59:59+00:00
Accession:  0001157523-23-000267
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA announces CEO transition: Jim Brown to succeed Kevin Guest as CEO effective July 1, 2023
--------------------------------------------------------------------------------

- Kevin Guest will transition to Executive Chairman; Jim Brown named CEO effective July 1, 2023.
- Jim Brown has served as President since 2019, previously COO and Chief Production Officer.
- Kevin Guest has been CEO since 2015 and Chairman since 2020; will remain involved as Executive Chairman.
- Current compensation for both executives unchanged until July 1; new packages to be set by Compensation Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000115752323000267/0001157523-23-000267-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000115752323000267/a53317502.htm
  HTML page:      https://secwatch.observer/filing/0001157523-23-000267

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer